Two Sigma Advisers
RETA

Two Sigma Advisers’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Two Sigma Advisers’s Portfolio RETA Stock Details RETA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
2023
Q2 		$734K Sell
2023
Q1 		$3.2M Sell
2022
Q4 		$1.91M Buy
2022
Q3 		$628K Buy
2020
Q4 		– Sell
2020
Q3 		$5.07M Sell
2020
Q2 		$9.53M Buy
2020
Q1 		$908K Buy
2019
Q2 		– Sell
2019
Q1 		$270K Buy